Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
B1723 Deferiprone3 CitationSummary: Chelating agent -
B1925 DeoxyarbutinSummary: Tyrosinase inhibitor -
B1928 Diclofenac DiethylamineSummary: non-selective COX inhibitor -
B1929 Diclofenac PotassiumSummary: nonsteroidal anti-inflammatory drug -
B1941 Estradiol BenzoateSummary: Estrogen/progestogen receptor agonist -
B1755 Fidaxomicin10 CitationSummary: macrocyclic antibiotic -
B1761 FlumethasoneTarget: Glucocorticoid ReceptorsSummary: Glucocorticoid receptor agonist -
B1772 Ibandronate sodiumTarget: Bone resorptionSummary: Potent bisphosphonate drug -
B1784 Levobupivacaine HClSummary: Sodium channel inhibitor -
B2114 Mitoxantrone HCl2 CitationTarget: Pim|Topoisomerases|USP|HIV IntegrasesSummary: Topoisomerase II inhibitor, anti-neoplastic drug


